Cyclin Dependent Kinases in Antiviral Drug Discovery

Olga Tarasova1, Walter Filgueira de Azevedo Junior2

  • 1Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya st., Moscow, 119121, Russia.

Current Medicinal Chemistry
|February 11, 2025
PubMed

Insights

Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle and are being explored as targets for antiviral therapies. Inhibitors of these kinases show promise in combating viral infections by targeting host replication factors.

Area of Science:

  • Molecular Biology
  • Virology
  • Pharmacology

Background:

  • Cyclin-dependent kinases (CDKs) regulate the cell cycle and are established therapeutic targets for cancer and inflammation.
  • Their role in viral replication has led to investigations into CDK inhibitors as novel antiviral strategies.
  • Targeting host factors is crucial due to increasing viral resistance to conventional treatments.

Purpose of the Study:

  • To analyze the molecular mechanisms of viral infection controlled by CDKs.
  • To explore the potential of CDK inhibitors and regulators as antiviral agents.
  • To review recent advancements in developing CDK-based antivirals, including their efficacy, side effects, and toxicities.

Main Methods:

  • Literature review focusing on the interplay between CDKs and viral replication.
  • Analysis of molecular mechanisms underlying CDK involvement in various viral infections.
  • Compilation and assessment of data on existing and emerging CDK inhibitors as antiviral agents.

Main Results:

  • CDKs play a significant role as host factors in the replication of various viruses.
  • CDK inhibitors demonstrate potential antiviral activity by disrupting viral replication cycles.
  • Research is ongoing to optimize these inhibitors for efficacy and safety against diverse viral pathogens.

Conclusions:

  • CDK inhibitors represent a promising class of antiviral agents by targeting essential host machinery.
  • Understanding CDK-viral interactions is key to developing effective strategies against drug-resistant viruses.
  • Further research is needed to fully elucidate the therapeutic potential and mitigate the toxicities of CDK-based antivirals.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K